CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Expanding Translational Research Concepts With Genedata Profiler

  The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.

• Automation And Digital Solutions Can Help You Reach Your mRNA Manufacturing And Sustainability Goals

  Explore how digital solutions help streamline mRNA manufacturing by reducing costs, improving efficiency, and supporting sustainability by creating paperless processes for emerging therapeutics.

• Mixed4Sure One2Fill

  Streamline bioprocessing with integrated mixing, filtration, and aliquoting solutions that help reduce product loss, improve consistency, and enhance contamination control.

• Unlocking Durable Allogeneic Cell Therapy

  Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

• Accelerating CAR T-Cell Therapy Manufacturing For Autoimmune Disease

  Proactive alignment and integrated quality systems can shorten cell therapy timelines. Rapid tech transfer and in-house analytics support regulatory rigor and reduce scaling risks.

• Smart Scaling For Cell And Gene Therapies

  To meet patient demand, advanced therapy manufacturing processes must be commercial ready. CGT sponsors can mitigate risk and protect viability by partnering with a CDMO that prioritizes scalability.

• Quantifying Lentiviral Physical Titer Using The QIAcuity dPCR System

  Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

• Characterizing AAV Payload With GMP-Compliant svAUC

  Ensuring AAV quality starts with payload characterization. Learn why conventional methods may miss key capsid population insights.

• Reducing Cost Drivers And Improving Efficiency In CAR T Cell Manufacturing

  Fragmented CAR T cell manufacturing workflows drive up costs and extend timelines. This case study quantifies what consolidating manufacturing and QC through automation actually delivers.

• Correlating NGS Success With Sample Input Quality: A Large Scale Study

  DIN values offer a data‑backed way to identify which DNA samples are ready for successful sequencing. With strong correlations to sequencing performance, DIN thresholds help streamline workflows.